HOME >> MEDICINE >> NEWS
Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years

PARSIPPANY, N.J., June 5, 2000 -- Aventis Pharmaceuticals announced today that Allegra® (fexofenadine HCl) 30-mg tablets, twice daily (BID), are now available by prescription for the relief of seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (CIU) in children aged 6 to 11 years.

"Seasonal allergies affect up to six million children in the United States," said Eli Meltzer, M.D., of the Allergy and Asthma Group and Research Center, San Diego, California and lead investigator of the clinical study, Safety of Fexofenadine HCl in Children Treated for Seasonal Allergic Rhinitis. "Allegra 30-mg tablets offer physicians a safe, nonsedating allergy treatment that can help in the management of children's seasonal allergies."

In a study of 411 pediatric patients, Allegra 30-mg tablets BID significantly reduced total symptom scores compared to placebo and was well tolerated among children aged 6 to 11 years. Such allergy symptoms, including runny nose, itchy, watery, red eyes, sneezing and itchy nose, palate and throat can hinder the enjoyment of outdoor activities that children like to pursue.

Allegra 30-mg tablets are nonchewable and are smaller than a chocolate chip. This pediatric dose is an addition to the Allegra family of products currently available for patients 12 and older, including Allegra® (fexofenadine HCl) 60-mg capsules, Allegra-D® (fexofenadine HCl 60 mg/pseudoephedrine HCl 120 mg) Extended-Release Tablets and Allegra® (fexofenadine HCl) 180-mg tablets.

Side-Effect Profile
In clinical trials, adverse events with Allegra 30-mg tablets were similar to placebo. The most commonly reported with Allegra 30-mg tablets and placebo in seasonal allergic rhinitis patients 6-11 years are headache (7.2% vs. 6.6%), upper respiratory tract infection (4.3% vs. 1.7%), coughing (3.8% vs. 1.3%), and accidental injury (2.9% vs. 1.3%).

Allegra 60-mg capsules are well tolerated with side effects similar to placebo.
'"/>

Contact: Charles F. Rouse III
973-394-6050
Porter Novelli
4-Jun-2000


Page: 1 2 3

Related medicine news :

1. Aventis Pasteur ready to meet nations needs for tetanus and diphtheria vaccine
2. Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
3. Aventis Pasteur statement on HVTN 501 decision
4. Millennium, Aventis Pharma form novel alliance
5. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
6. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
7. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
8. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
9. Pharmaceuticals and personal care products
10. Nortran Pharmaceuticals Inc. and Hoechst Marion Roussel announce collaborativeagreement
11. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... With a petition (case CJ-2018-04177) filed ... McLain PLLC joins a series of lawsuits filed in states around the country against ... Massage Envy locations by Massage Envy’s massage therapists. , This lawsuit alleges that ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... its mission to provide simple, easy-to-use software for biopharma companies. By pairing the ... quickly answer those crucial resourcing questions without spending millions of dollars implementing a ...
(Date:10/16/2018)... Va. (PRWEB) , ... October 16, 2018 , ... ... Oct. 23-25, 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual ... last year’s Inspections Summit that it sometimes feels difficult to keep up. The ...
(Date:10/16/2018)... Maine (PRWEB) , ... October 15, 2018 , ... ... Fluids product line, VALIDATE® Body Fluids, Order Number 205bf, for easier linearity and ... assist in the documentation of linearity, calibration verification and verification of the reportable ...
(Date:10/16/2018)... ... October 16, 2018 , ... AutismOne, ... host the proceedings of the 4th Annual International HPV Vaccine Education Symposium. , ... Wednesday, May 22, 2019, through Friday, May 24, 2019, with a keynote address ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... Association Gloves & Supplies, ... alliance with The Dentists Supply Company (TDSC). TDSC operates an online ... catalog of dental supplies through tdsc.com. This strategic alliance enhances the value proposition ...
(Date:10/16/2018)... , ... October 16, 2018 , ... Cameras and monitoring ... of the home where safety plays a key role in a family’s health and ... of “Today’s Homeowner” TV hosted a “Safe At Home” satellite media event today. ...
(Date:10/16/2018)... ... October 16, 2018 , ... The iaedp™ Foundation, ... group of healthcare treatment providers who treat the full spectrum of eating disorder ... live, two-day, 12-hour track at Symposium 2019. The courses are regularly offered ...
Breaking Medicine Technology:
Cached News: